Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18632871 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | April 2024 | April 2025 | Allow | 12 | 2 | 0 | No | No |
| 18615574 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | March 2024 | September 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18511300 | APPLICATION OF BACILLUS COAGULANS IN PREPARING MEDICATION FOR IMPROVING FUNCTIONAL DECLINE OF ORGANISMS CAUSED BY HYPERGLYCEMIA AND HYPERLIPIDEMIA | January 2024 | April 2025 | Abandon | 17 | 1 | 0 | No | No |
| 18394616 | RUMINANT COMPOSITIONS | December 2023 | April 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18381418 | CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF | October 2023 | April 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18380292 | METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS | October 2023 | March 2025 | Abandon | 17 | 0 | 1 | No | No |
| 18464379 | METHOD AND SYSTEMS FOR ISOLATION AND/OR SEPARATION OF PRODUCTS FROM PRODUCTION PROCESSES | September 2023 | May 2025 | Allow | 20 | 3 | 0 | Yes | No |
| 18460124 | BACILLUS COAGULANS FOR IMPROVING CONSTIPATION AND APPLICATION THEREOF | September 2023 | November 2024 | Abandon | 15 | 2 | 0 | No | No |
| 18222943 | METHOD OF INHIBITING MYCOTOXIN GROWTH USING ARTHROSPIRA PLATENSIS NANOPARTICLES | July 2023 | October 2023 | Allow | 3 | 1 | 0 | Yes | No |
| 18210234 | ALGAE-BASED BIOPLASTICS AND METHODS OF MAKING | June 2023 | October 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18204664 | COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF | June 2023 | November 2024 | Abandon | 18 | 1 | 0 | No | No |
| 18313312 | TYPE E BOTULINUM TOXIN TO TREAT BOTULISM | May 2023 | March 2024 | Abandon | 10 | 1 | 0 | No | No |
| 18140799 | METHOD OF INHIBITING MYCOTOXIN GROWTH USING ARTHROSPIRA PLATENSIS NANOPARTICLES | April 2023 | October 2023 | Allow | 6 | 1 | 1 | No | No |
| 18124346 | CELL CULTURE METHOD FOR MESENCHYMAL STEM CELLS | March 2023 | September 2024 | Allow | 18 | 1 | 0 | Yes | No |
| 18179839 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | March 2023 | September 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18179801 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | March 2023 | September 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18112785 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DEGENERATIVE MITRAL VALVE DISEASE IN A CANINE | February 2023 | February 2024 | Allow | 12 | 1 | 0 | No | No |
| 18171650 | METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS | February 2023 | November 2024 | Allow | 21 | 1 | 0 | No | No |
| 18171647 | METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS | February 2023 | November 2024 | Allow | 21 | 1 | 0 | No | No |
| 18168163 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | February 2023 | May 2025 | Abandon | 27 | 2 | 0 | No | No |
| 17926979 | A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT | November 2022 | June 2025 | Allow | 30 | 0 | 0 | No | No |
| 17937853 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | October 2022 | January 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17942812 | METHOD OF CULTIVATING ALGAE AND PHOTOBIOREACTOR | September 2022 | September 2024 | Allow | 25 | 1 | 0 | No | No |
| 17899561 | METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT | August 2022 | September 2024 | Abandon | 25 | 1 | 0 | No | No |
| 17876314 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | July 2022 | March 2023 | Allow | 7 | 2 | 0 | No | No |
| 17870093 | COMBINATION THERAPY USING CLOSTRIDIAL TOXIN DERIVATIVE AND AT LEAST ONE CHEMICAL DEPOLARIZING AGENT | July 2022 | November 2024 | Abandon | 28 | 0 | 1 | No | No |
| 17869863 | METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT | July 2022 | September 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17836440 | METHODS FOR TREATING COSTIMULATION BLOCKADE RESISTANT REJECTION | June 2022 | July 2024 | Abandon | 26 | 2 | 0 | No | No |
| 17834252 | Isolated Bacterial Strain of the Genus Burkholderia and Pesticidal Metabolites Therefrom | June 2022 | April 2024 | Allow | 23 | 1 | 0 | Yes | No |
| 17825132 | EXTRACORPOREAL TREATMENT FOR AGING | May 2022 | February 2025 | Abandon | 33 | 0 | 1 | No | No |
| 17742753 | METHODS OF TREATING CELIAC DISEASE | May 2022 | March 2024 | Abandon | 22 | 1 | 0 | No | No |
| 17743097 | DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS | May 2022 | April 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17735466 | COMPOSITION AND METHODS FOR PROCESSING A SPUTUM SAMPLE | May 2022 | February 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17735743 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | May 2022 | November 2022 | Allow | 7 | 1 | 0 | No | No |
| 17728399 | Methods for Preparation of a Terminally Sterilized Hydrogel Derived from Extracellular Matrix | April 2022 | February 2024 | Allow | 21 | 1 | 0 | No | No |
| 17727465 | MICROBIOME MARKERS AND USES THEREOF | April 2022 | March 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17720240 | Amelioration and Treatment of Opioid Addiction | April 2022 | April 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17762348 | SEMINAPHTHOFLUOROPHORE-SELENIUM PROBES FOR THIOREDOXIN REDUCTASE | March 2022 | March 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17760740 | RAPID CELL CULTURE TEST DEVICE DESIGNED SUCH THAT FLUID FILMS WITH UNIFORM THICKNESS ARE FORMED | March 2022 | January 2025 | Allow | 34 | 1 | 0 | No | No |
| 17681529 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | February 2022 | July 2022 | Allow | 4 | 1 | 0 | Yes | No |
| 17635161 | CHIMERIC VESICULOVIRUSES AND METHODS OF USE | February 2022 | February 2025 | Allow | 36 | 1 | 0 | No | No |
| 17589162 | THERAPEUTIC AGENT FOR DISC HERNIATION | January 2022 | November 2023 | Allow | 22 | 1 | 0 | No | No |
| 17545911 | FERMENT FROM STRUCTURED WATER MEDIUM AND COSMETIC COMPOSITION COMPRISING THE SAME | December 2021 | March 2025 | Allow | 39 | 3 | 1 | Yes | No |
| 17539186 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | November 2021 | July 2022 | Allow | 8 | 2 | 1 | Yes | No |
| 17615241 | DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT | November 2021 | March 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17524154 | MICROBES AND METHODS FOR PRODUCING THE SAME | November 2021 | September 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17499014 | Use of Burkholderia Formulations, Compositions and Compounds to Modulate Crop Yield and/or Corn Rootworm Infestation | October 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17498391 | METHOD FOR DETERMINING WHETHER OR NOT TEST SAMPLE CONTAINS PHYTOPATHOGENIC FUNGUS | October 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17496398 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | October 2021 | May 2022 | Allow | 7 | 1 | 0 | Yes | No |
| 17489454 | METHOD FOR THE GENERATION OF COMPACT TALE-NUCLEASES AND USES THEREOF | September 2021 | June 2025 | Abandon | 45 | 1 | 0 | No | No |
| 16606158 | COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE | September 2021 | September 2024 | Abandon | 59 | 1 | 0 | No | No |
| 17479230 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Device for Delivering Them | September 2021 | July 2024 | Allow | 34 | 2 | 0 | No | No |
| 17440566 | NOVEL LACTIC ACID BACTERIA STRAINS THAT PROMOTE THE ABSORPTION OF CALCIUM - PEPTIDES AND ASSOCIATED PRODUCTS | September 2021 | February 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17434577 | FOOD MATERIALS COMPRISING FILAMENTOUS FUNGAL PARTICLES AND MEMBRANE BIOREACTOR DESIGN | August 2021 | March 2025 | Allow | 42 | 1 | 0 | No | No |
| 17412177 | PHOSPHATE-SOLUBILIZING MICROBIAL AGENT FOR MAIZE, AND PREPARATION METHOD AND USE THEREOF | August 2021 | March 2025 | Abandon | 43 | 2 | 1 | Yes | No |
| 17409181 | NOVEL BACTERIA AND USES THEREOF | August 2021 | March 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17429237 | COMBINATION THERAPY USING CLOSTRIDIAL TOXIN DERIVATIVE AND AT LEAST ONE CHEMICAL DEPOLARIZING AGENT | August 2021 | November 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17425079 | NOVEL KAZACHSTANIA TURICENSIS CAU Y1706 AND COMPOSITION USING SAME | July 2021 | August 2024 | Allow | 37 | 2 | 0 | No | No |
| 17378468 | METHOD FOR DETERMINING WHETHER OR NOT TEST SAMPLE CONTAINS PHYTOPATHOGENIC FUNGUS | July 2021 | July 2023 | Allow | 24 | 1 | 0 | No | No |
| 17422868 | Bile Acids and Use in Disease Treatment | July 2021 | January 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17369012 | MULTIPLEXED SPECTRAL LIFETIME DETECTION OF PHOSPHORS | July 2021 | September 2023 | Abandon | 26 | 0 | 1 | No | No |
| 17368282 | FEED ADDITIVE COMPOSITION | July 2021 | October 2023 | Allow | 28 | 1 | 0 | No | No |
| 17419480 | Methods of Producing Ustekinumab | June 2021 | January 2025 | Allow | 43 | 1 | 0 | No | No |
| 17354967 | THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES | June 2021 | October 2023 | Allow | 28 | 1 | 0 | Yes | No |
| 17351548 | METHOD FOR THE PRODUCTION OF A DAIRY FOOD PRODUCT AND A METHOD FOR GENE TRANSFER BY CONJUGATION | June 2021 | October 2023 | Allow | 28 | 1 | 0 | No | No |
| 17349366 | METHOD FOR REDUCING BLOOD URIC ACID CONCENTRATION AND FOR DEGRADING PURINE | June 2021 | June 2023 | Allow | 24 | 1 | 0 | No | No |
| 17343712 | TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS | June 2021 | September 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17299476 | COUPLED SORTING AND ELECTRIC TREATMENT OF BIOLOGICAL CELLS | June 2021 | February 2025 | Allow | 45 | 1 | 1 | No | No |
| 17292092 | IMPROVED PRODUCTION OF SYMMETRICAL BOLAFORM SOPHOROSIDES | May 2021 | August 2024 | Allow | 39 | 1 | 0 | Yes | No |
| 17245416 | METHODS FOR PRODUCING A POLYACTIVE CARBOHYDRATE AND APPLICATIONS THEREOF | April 2021 | September 2024 | Allow | 40 | 1 | 1 | Yes | No |
| 17288786 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS AND IMPROVING PLANT HEALTH | April 2021 | October 2024 | Allow | 42 | 1 | 0 | No | No |
| 17286855 | IN VIVO FLUORINATION | April 2021 | June 2025 | Abandon | 50 | 1 | 2 | No | No |
| 17231101 | METHOD FOR DETERMINING LIKELIHOOD OF AN INFLAMMATORY GASTROINTESTINAL TRACT DISEASE | April 2021 | November 2023 | Allow | 31 | 0 | 1 | No | No |
| 17222022 | METHOD FOR MANUFACTURING WATER-IN-OIL-IN-WATER MULTIPLE EMULSION | April 2021 | April 2024 | Allow | 36 | 2 | 0 | Yes | No |
| 17207164 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | March 2021 | August 2023 | Allow | 29 | 1 | 0 | Yes | No |
| 17275354 | Stable Granules for Feed Compositions | March 2021 | October 2024 | Allow | 43 | 1 | 1 | Yes | No |
| 17195240 | FARBER DISEASE MARKERS AND USES THEREOF | March 2021 | March 2025 | Abandon | 48 | 1 | 1 | No | No |
| 17192193 | METHOD FOR TESTING BODY FLUIDS | March 2021 | September 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17272965 | INDUSTRIAL APPLICATIONS OF PLANT CELL EXTRACTS COMPRISING SOD ENZYMES OF EXTREMOPHILIC MICRO-ORGANISMS | March 2021 | August 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17272393 | METHODS AND COMPOSITIONS FOR INDUCING NEURAL PLASTICITY | March 2021 | July 2024 | Allow | 40 | 2 | 0 | No | No |
| 17181160 | DETECTION OF GLUTATHIONYLATED PROTEINS | February 2021 | September 2024 | Allow | 43 | 1 | 1 | Yes | No |
| 17180727 | PREPARATION METHOD AND APPLICATION OF SEA CUCUMBER PROTEIN PEPTIDES | February 2021 | August 2024 | Abandon | 42 | 1 | 1 | No | No |
| 17268781 | METHODS OF DECREASING DYSBIOSIS AND RESTORING A MICROBIOME | February 2021 | July 2024 | Allow | 41 | 2 | 0 | No | No |
| 17167976 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | February 2021 | October 2021 | Allow | 8 | 1 | 1 | Yes | No |
| 17153425 | CHROMOGENIC ABSORBENT MATERIAL FOR ANIMAL LITTER | January 2021 | February 2024 | Allow | 37 | 1 | 0 | No | No |
| 17260731 | MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF BEE BREAD | January 2021 | November 2024 | Allow | 46 | 3 | 1 | No | No |
| 17145352 | METHOD FOR MANUFACTURE OF DEMINERALIZED BIOCOMPOSITE MATERIALS | January 2021 | January 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17104011 | COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF | November 2020 | February 2023 | Allow | 27 | 1 | 0 | No | No |
| 17103248 | METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS | November 2020 | August 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 17089893 | METHOD AND SYSTEMS FOR ISOLATION AND/OR SEPARATION OF PRODUCTS FROM PRODUCTION PROCESSES | November 2020 | June 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 17088355 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | November 2020 | May 2021 | Allow | 7 | 0 | 0 | Yes | No |
| 17072128 | CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF | October 2020 | July 2023 | Allow | 33 | 1 | 0 | No | No |
| 17061624 | METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS | October 2020 | July 2023 | Allow | 34 | 1 | 0 | Yes | No |
| 17061074 | METHOD FOR OBTAINING LOW ETHANOL-PRODUCING YEAST STRAINS, YEAST STRAINS OBTAINED THEREFROM AND THEIR USE | October 2020 | July 2023 | Abandon | 34 | 0 | 1 | No | No |
| 17027391 | FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE | September 2020 | August 2023 | Allow | 35 | 1 | 1 | Yes | No |
| 17026561 | METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE | September 2020 | July 2023 | Abandon | 34 | 0 | 1 | No | No |
| 17025811 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS | September 2020 | October 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 17022805 | SPORE-BASED PROBIOTIC SUPPLEMENTATION IN CHICKENS AND EFFECT ON SALMONELLA LOADS | September 2020 | December 2022 | Abandon | 27 | 1 | 0 | No | No |
| 17017122 | METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS | September 2020 | August 2023 | Abandon | 35 | 1 | 1 | No | No |
| 17012533 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | September 2020 | April 2021 | Allow | 8 | 0 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAGUIO FRISING, MICHELLE F.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PAGUIO FRISING, MICHELLE F works in Art Unit 1651 and has examined 577 patent applications in our dataset. With an allowance rate of 67.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 28 months.
Examiner PAGUIO FRISING, MICHELLE F's allowance rate of 67.9% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PAGUIO FRISING, MICHELLE F receive 1.60 office actions before reaching final disposition. This places the examiner in the 42% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by PAGUIO FRISING, MICHELLE F is 28 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +47.6% benefit to allowance rate for applications examined by PAGUIO FRISING, MICHELLE F. This interview benefit is in the 93% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 33.1% of applications are subsequently allowed. This success rate is in the 64% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 54.4% of cases where such amendments are filed. This entry rate is in the 76% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 160.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 42% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 56.1% are granted (fully or in part). This grant rate is in the 71% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.0% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.